Determination of vascular-endothelial growth factor levels in serum from tumor-bearing BALB/c mice treated with photodynamic therapy

Medical Science Monitor

Volumn 9, Issue 4, 2003, Pages

  Osiecka, Beata J ^a   Ziółkowski, Piotr ^a   Gamian, Elzbieta ^a   Lis Nawara, Anna ^a   White, Stephen G ^b   Bonnett, Raymond ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiogenesis; Fibrosarcoma; Gallium phthalocyanine tetrasulfonate; Photodynamic therapy; VEGF

Indexed keywords

BON 6; GALLIUM; HYDROXYGALLIUM PHTHALOCYANINE TETRASULFONIC ACID TETRASODIUM SALT; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CANCER THERAPY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; IRRADIATION; LIGHT; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; SERUM; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR GROWTH;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FIBROSARCOMA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; SURVIVAL RATE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037545757     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bonnett R: Photodynamic therapy in historical perspective. Rev Contemp Pharmacother, 1999; 10: 1-17
2. Schuitmaker JJ, Baas P, van Leengoed HLLM et al: Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol B: Biol, 1996; 34: 3-12
3. Bonnett R, editor: Chemical Aspects of Photodynamic Therapy. Amsterdam: Gordon & Breach Science Publishers, 2000
4. Ochsner M: Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol B: Biol, 1997; 39: 1-18
5. Ziółkowski P, Symonowicz K, Milach J: In vivo interleukin-1-alpha induction following chlorin e6 photodynamic therapy in BALB/c mice. Proc SPIE, 1996; 2625: 426-433
6. Ziółkowski P, Symonowicz K, Milach J et al: In vivo Tumor Necrosis Factor-alpha induction following chlorin e6-photodynamic therapy. Neoplasma, 1997; 44: 192-196
7. Ziółkowski P, Symonowicz K, Osiecka BJ et al: Photodynamic treatment of epithelial tissue derived from patients with endometrial cancer: a contribution to the role of laminin and epidermal growth factor receptor in photodynamic therapy. J Biomed Opt, 1999; 4: 272-275
8. Klagsbrun M, Soker S: VEGF/VPF: the angiogenesis factor found? Current Biol, 1993; 3: 699-702
9. Ferrara N, Houck KA, Jakeman LB et al: The vascular endothelial growth factor family of polypeptides. J Cell Biochem, 1991; 47: 211-218
10. D'Amore PA: Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci, 1994; 35: 3974-3979
11. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat, 1995; 36: 127-137
12. Fox SB, Gatter KC, Harris AL: Tumour angiogenesis. J Pathol, 1996; 179: 232-237
13. Ali H, Langlois R, Wagner JR et al: Biological activities of phthalocyanines. X Synthesis and analysis of sulfonated phthalocyanines. Photochem Photobiol, 1988; 47: 713-717
14. Bonnett R, Nizhnik AN, White SG, Berenbaum MB: Porphyrin sensitisers in tumour phototherapy. Novel sensitisers of the chlorin and bacteriochlorin class with amphiphilic properties. J Photochem Photobiol B: Biol, 1990; 6: 29-37
15. Robbins SG, Conaway JR, Ford BL et al: Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina. Growth Factors, 1997; 14: 229-241
16. Ferrario A, von Tiehl KF, Rucker N et al: Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 2000; 60: 4066-4069
17. Houck K, Ferrara N, Winerj et al: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinology, 1991; 5: 1806-1813
18. Nash AD: Fibrosarcoma and fibromatosis. In: Silverberg SG, editor. Soft Tissue Sarcomas. Histological diagnosis. Biopsy Interpretation Series. New York Raven Press, 1989; 9-20
19. Takahashi Y, Kitadai Y, Bucana CD et al: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res, 1995; 55: 3964-3968
20. Jee SH, Shen SC, Chiu HC et al: Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene, 2001; 20: 198-208
21. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem, 1995; 270: 13333-13340